Article submission-guidelines not found dismiss

Discover and publish cutting edge, open research.

Browse 69,840 multi-disciplinary research preprints

Featured documents

Michael Weekes

and 11 more

Nick K. Jones1,2*, Lucy Rivett1,2*, Chris Workman3, Mark Ferris3, Ashley Shaw1, Cambridge COVID-19 Collaboration1,4, Paul J. Lehner1,4, Rob Howes5, Giles Wright3, Nicholas J. Matheson1,4,6¶, Michael P. Weekes1,7¶1 Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK2 Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, UK3 Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, UK4 Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK5 Cambridge COVID-19 Testing Centre and AstraZeneca, Anne Mclaren Building, Cambridge, UK6 NHS Blood and Transplant, Cambridge, UK7 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK*Joint first authorship¶Joint last authorshipCorrespondence: [email protected] UK has initiated mass COVID-19 immunisation, with healthcare workers (HCWs) given early priority because of the potential for workplace exposure and risk of onward transmission to patients. The UK’s Joint Committee on Vaccination and Immunisation has recommended maximising the number of people vaccinated with first doses at the expense of early booster vaccinations, based on single dose efficacy against symptomatic COVID-19 disease.1-3At the time of writing, three COVID-19 vaccines have been granted emergency use authorisation in the UK, including the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). A vital outstanding question is whether this vaccine prevents or promotes asymptomatic SARS-CoV-2 infection, rather than symptomatic COVID-19 disease, because sub-clinical infection following vaccination could continue to drive transmission. This is especially important because many UK HCWs have received this vaccine, and nosocomial COVID-19 infection has been a persistent problem.Through the implementation of a 24 h-turnaround PCR-based comprehensive HCW screening programme at Cambridge University Hospitals NHS Foundation Trust (CUHNFT), we previously demonstrated the frequent presence of pauci- and asymptomatic infection amongst HCWs during the UK’s first wave of the COVID-19 pandemic.4 Here, we evaluate the effect of first-dose BNT162b2 vaccination on test positivity rates and cycle threshold (Ct) values in the asymptomatic arm of our programme, which now offers weekly screening to all staff.Vaccination of HCWs at CUHNFT began on 8th December 2020, with mass vaccination from 8th January 2021. Here, we analyse data from the two weeks spanning 18thto 31st January 2021, during which: (a) the prevalence of COVID-19 amongst HCWs remained approximately constant; and (b) we screened comparable numbers of vaccinated and unvaccinated HCWs. Over this period, 4,408 (week 1) and 4,411 (week 2) PCR tests were performed from individuals reporting well to work. We stratified HCWs <12 days or > 12 days post-vaccination because this was the point at which protection against symptomatic infection began to appear in phase III clinical trial.226/3,252 (0·80%) tests from unvaccinated HCWs were positive (Ct<36), compared to 13/3,535 (0·37%) from HCWs <12 days post-vaccination and 4/1,989 (0·20%) tests from HCWs ≥12 days post-vaccination (p=0·023 and p=0·004, respectively; Fisher’s exact test, Figure). This suggests a four-fold decrease in the risk of asymptomatic SARS-CoV-2 infection amongst HCWs ≥12 days post-vaccination, compared to unvaccinated HCWs, with an intermediate effect amongst HCWs <12 days post-vaccination.A marked reduction in infections was also seen when analyses were repeated with: (a) inclusion of HCWs testing positive through both the symptomatic and asymptomatic arms of the programme (56/3,282 (1·71%) unvaccinated vs 8/1,997 (0·40%) ≥12 days post-vaccination, 4·3-fold reduction, p=0·00001); (b) inclusion of PCR tests which were positive at the limit of detection (Ct>36, 42/3,268 (1·29%) vs 15/2,000 (0·75%), 1·7-fold reduction, p=0·075); and (c) extension of the period of analysis to include six weeks from December 28th to February 7th 2021 (113/14,083 (0·80%) vs 5/4,872 (0·10%), 7·8-fold reduction, p=1x10-9). In addition, the median Ct value of positive tests showed a non-significant trend towards increase between unvaccinated HCWs and HCWs > 12 days post-vaccination (23·3 to 30·3, Figure), suggesting that samples from vaccinated individuals had lower viral loads.We therefore provide real-world evidence for a high level of protection against asymptomatic SARS-CoV-2 infection after a single dose of BNT162b2 vaccine, at a time of predominant transmission of the UK COVID-19 variant of concern 202012/01 (lineage B.1.1.7), and amongst a population with a relatively low frequency of prior infection (7.2% antibody positive).5This work was funded by a Wellcome Senior Clinical Research Fellowship to MPW (108070/Z/15/Z), a Wellcome Principal Research Fellowship to PJL (210688/Z/18/Z), and an MRC Clinician Scientist Fellowship (MR/P008801/1) and NHSBT workpackage (WPA15-02) to NJM. Funding was also received from Addenbrooke’s Charitable Trust and the Cambridge Biomedical Research Centre. We also acknowledge contributions from all staff at CUHNFT Occupational Health and Wellbeing and the Cambridge COVID-19 Testing Centre.

Guangming Wang

and 4 more

Tam Hunt

and 1 more

Tam Hunt [1], Jonathan SchoolerUniversity of California Santa Barbara Synchronization, harmonization, vibrations, or simply resonance in its most general sense seems to have an integral relationship with consciousness itself. One of the possible “neural correlates of consciousness” in mammalian brains is a combination of gamma, beta and theta synchrony. More broadly, we see similar kinds of resonance patterns in living and non-living structures of many types. What clues can resonance provide about the nature of consciousness more generally? This paper provides an overview of resonating structures in the fields of neuroscience, biology and physics and attempts to coalesce these data into a solution to what we see as the “easy part” of the Hard Problem, which is generally known as the “combination problem” or the “binding problem.” The combination problem asks: how do micro-conscious entities combine into a higher-level macro-consciousness? The proposed solution in the context of mammalian consciousness suggests that a shared resonance is what allows different parts of the brain to achieve a phase transition in the speed and bandwidth of information flows between the constituent parts. This phase transition allows for richer varieties of consciousness to arise, with the character and content of that consciousness in each moment determined by the particular set of constituent neurons. We also offer more general insights into the ontology of consciousness and suggest that consciousness manifests as a relatively smooth continuum of increasing richness in all physical processes, distinguishing our view from emergentist materialism. We refer to this approach as a (general) resonance theory of consciousness and offer some responses to Chalmers’ questions about the different kinds of “combination problem.”  At the heart of the universe is a steady, insistent beat: the sound of cycles in sync…. [T]hese feats of synchrony occur spontaneously, almost as if nature has an eerie yearning for order. Steven Strogatz, Sync: How Order Emerges From Chaos in the Universe, Nature and Daily Life (2003) If you want to find the secrets of the universe, think in terms of energy, frequency and vibration.Nikola Tesla (1942) I.               Introduction Is there an “easy part” and a “hard part” to the Hard Problem of consciousness? In this paper, we suggest that there is. The harder part is arriving at a philosophical position with respect to the relationship of matter and mind. This paper is about the “easy part” of the Hard Problem but we address the “hard part” briefly in this introduction.  We have both arrived, after much deliberation, at the position of panpsychism or panexperientialism (all matter has at least some associated mind/experience and vice versa). This is the view that all things and processes have both mental and physical aspects. Matter and mind are two sides of the same coin.  Panpsychism is one of many possible approaches that addresses the “hard part” of the Hard Problem. We adopt this position for all the reasons various authors have listed (Chalmers 1996, Griffin 1997, Hunt 2011, Goff 2017). This first step is particularly powerful if we adopt the Whiteheadian version of panpsychism (Whitehead 1929).  Reaching a position on this fundamental question of how mind relates to matter must be based on a “weight of plausibility” approach, rather than on definitive evidence, because establishing definitive evidence with respect to the presence of mind/experience is difficult. We must generally rely on examining various “behavioral correlates of consciousness” in judging whether entities other than ourselves are conscious – even with respect to other humans—since the only consciousness we can know with certainty is our own. Positing that matter and mind are two sides of the same coin explains the problem of consciousness insofar as it avoids the problems of emergence because under this approach consciousness doesn’t emerge. Consciousness is, rather, always present, at some level, even in the simplest of processes, but it “complexifies” as matter complexifies, and vice versa. Consciousness starts very simple and becomes more complex and rich under the right conditions, which in our proposed framework rely on resonance mechanisms. Matter and mind are two sides of the coin. Neither is primary; they are coequal.  We acknowledge the challenges of adopting this perspective, but encourage readers to consider the many compelling reasons to consider it that are reviewed elsewhere (Chalmers 1996, Griffin 1998, Hunt 2011, Goff 2017, Schooler, Schooler, & Hunt, 2011; Schooler, 2015).  Taking a position on the overarching ontology is the first step in addressing the Hard Problem. But this leads to the related questions: at what level of organization does consciousness reside in any particular process? Is a rock conscious? A chair? An ant? A bacterium? Or are only the smaller constituents, such as atoms or molecules, of these entities conscious? And if there is some degree of consciousness even in atoms and molecules, as panpsychism suggests (albeit of a very rudimentary nature, an important point to remember), how do these micro-conscious entities combine into the higher-level and obvious consciousness we witness in entities like humans and other mammals?  This set of questions is known as the “combination problem,” another now-classic problem in the philosophy of mind, and is what we describe here as the “easy part” of the Hard Problem. Our characterization of this part of the problem as “easy”[2] is, of course, more than a little tongue in cheek. The authors have discussed frequently with each other what part of the Hard Problem should be labeled the easier part and which the harder part. Regardless of the labels we choose, however, this paper focuses on our suggested solution to the combination problem.  Various solutions to the combination problem have been proposed but none have gained widespread acceptance. This paper further elaborates a proposed solution to the combination problem that we first described in Hunt 2011 and Schooler, Hunt, and Schooler 2011. The proposed solution rests on the idea of resonance, a shared vibratory frequency, which can also be called synchrony or field coherence. We will generally use resonance and “sync,” short for synchrony, interchangeably in this paper. We describe the approach as a general resonance theory of consciousness or just “general resonance theory” (GRT). GRT is a field theory of consciousness wherein the various specific fields associated with matter and energy are the seat of conscious awareness.  A summary of our approach appears in Appendix 1.  All things in our universe are constantly in motion, in process. Even objects that appear to be stationary are in fact vibrating, oscillating, resonating, at specific frequencies. So all things are actually processes. Resonance is a specific type of motion, characterized by synchronized oscillation between two states.  An interesting phenomenon occurs when different vibrating processes come into proximity: they will often start vibrating together at the same frequency. They “sync up,” sometimes in ways that can seem mysterious, and allow for richer and faster information and energy flows (Figure 1 offers a schematic). Examining this phenomenon leads to potentially deep insights about the nature of consciousness in both the human/mammalian context but also at a deeper ontological level.

Susanne Schilling*^

and 9 more

Jessica mead

and 6 more

The construct of wellbeing has been criticised as a neoliberal construction of western individualism that ignores wider systemic issues including increasing burden of chronic disease, widening inequality, concerns over environmental degradation and anthropogenic climate change. While these criticisms overlook recent developments, there remains a need for biopsychosocial models that extend theoretical grounding beyond individual wellbeing, incorporating overlapping contextual issues relating to community and environment. Our first GENIAL model \cite{Kemp_2017} provided a more expansive view of pathways to longevity in the context of individual health and wellbeing, emphasising bidirectional links to positive social ties and the impact of sociocultural factors. In this paper, we build on these ideas and propose GENIAL 2.0, focusing on intersecting individual-community-environmental contributions to health and wellbeing, and laying an evidence-based, theoretical framework on which future research and innovative therapeutic innovations could be based. We suggest that our transdisciplinary model of wellbeing - focusing on individual, community and environmental contributions to personal wellbeing - will help to move the research field forward. In reconceptualising wellbeing, GENIAL 2.0 bridges the gap between psychological science and population health health systems, and presents opportunities for enhancing the health and wellbeing of people living with chronic conditions. Implications for future generations including the very survival of our species are discussed.  

Mark Ferris

and 14 more

IntroductionConsistent with World Health Organization (WHO) advice [1], UK Infection Protection Control guidance recommends that healthcare workers (HCWs) caring for patients with coronavirus disease 2019 (COVID-19) should use fluid resistant surgical masks type IIR (FRSMs) as respiratory protective equipment (RPE), unless aerosol generating procedures (AGPs) are being undertaken or are likely, when a filtering face piece 3 (FFP3) respirator should be used [2]. In a recent update, an FFP3 respirator is recommended if “an unacceptable risk of transmission remains following rigorous application of the hierarchy of control” [3]. Conversely, guidance from the Centers for Disease Control and Prevention (CDC) recommends that HCWs caring for patients with COVID-19 should use an N95 or higher level respirator [4]. WHO guidance suggests that a respirator, such as FFP3, may be used for HCWs in the absence of AGPs if availability or cost is not an issue [1].A recent systematic review undertaken for PHE concluded that: “patients with SARS-CoV-2 infection who are breathing, talking or coughing generate both respiratory droplets and aerosols, but FRSM (and where required, eye protection) are considered to provide adequate staff protection” [5]. Nevertheless, FFP3 respirators are more effective in preventing aerosol transmission than FRSMs, and observational data suggests that they may improve protection for HCWs [6]. It has therefore been suggested that respirators should be considered as a means of affording the best available protection [7], and some organisations have decided to provide FFP3 (or equivalent) respirators to HCWs caring for COVID-19 patients, despite a lack of mandate from local or national guidelines [8].Data from the HCW testing programme at Cambridge University Hospitals NHS Foundation Trust (CUHNFT) during the first wave of the UK severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic indicated a higher incidence of infection amongst HCWs caring for patients with COVID-19, compared with those who did not [9]. Subsequent studies have confirmed this observation [10, 11]. This disparity persisted at CUHNFT in December 2020, despite control measures consistent with PHE guidance and audits indicating good compliance. The CUHNFT infection control committee therefore implemented a change of RPE for staff on “red” (COVID-19) wards from FRSMs to FFP3 respirators. In this study, we analyse the incidence of SARS-CoV-2 infection in HCWs before and after this transition.

How it works

Upload or create your research work
You can upload Word, PDF, LaTeX as well as data, code, Jupyter Notebooks, videos, and figures. Or start a document from scratch.
Disseminate your research rapidly
Post your work as a preprint. A Digital Object Identifier (DOI) makes your research citeable and discoverable immediately.
Get published in a refereed journal
Track the status of your paper as it goes through peer review. When published, it automatically links to the publisher version.
Learn More

Most recent documents

Mai Duong

and 6 more

Aim: To investigate if interventions to discontinue or down-titrate heart failure (HF)-pharmacotherapy are feasible and associated with risks in older people. Methods: A systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines. Electronic databases were searched from inception to March 8th 2023. Randomised controlled trials (RCTs) and observational studies included people with HF, aged >50 years and who discontinued or down-titrated HF-pharmacotherapy. Outcomes were feasibility (whether discontinuation or down-titration of HF-pharmacotherapy was sustained at follow-up) and associated risks (mortality, hospitalisation, adverse drug withdrawal effects [ADWE]). Random-effects meta-analysis was performed when heterogeneity was not substantial (Higgins I2<70%). Sub-analysis by frailty status was conducted. Results: Six RCTs (536-participants) and 27 observational studies (810,499-participants) across six therapeutic classes were included, for 3-260 weeks follow-up. RCTs were conducted in patients presenting with stable HF. Down-titrating a renin-angiotensin system inhibitor (RASI) in patients with chronic kidney disease was 76% likely than continuation (Risk Ratio [RR] 1.76, 95%CI 1.14-2.73), with no difference in mortality (RR 0.64, 95%CI 0.30-1.64). Discontinuation of beta-blockers were feasible compared to continuation in preserved ejection fraction (RR 1.00, 95%CI 0.68-1.47). Participants were 25% likely to re-initiate discontinued diuretics (RR 0.75, 95%CI 0.66-0.86). Digoxin discontinuation was associated with 5.5-fold risk of hospitalisation compared to continuation. Worsening HF was the commonest ADWE. One observational study measured frailty but did not report outcomes by frailty status. Conclusions: The appropriateness and associated risks of down-titrating or discontinuing HF-pharmacotherapy in people aged >75 years is uncertain. Evaluation of outcomes by frailty status necessitates investigation.

xiaoxiao dong

and 4 more

Massive malignant phyllodes tumor accompanied by anemia and ulceration in the breast: A case reportAttention:Written informed consent was obtained from the patient to publish this report in accordance with the journal’s patient consent policy.[Abstract] Large malignant breast phyllodes tumors are uncommon in clinical settings. Here, we report such a case to provide a reference for clinical work. A 48-year-old woman discovered a lump in her right breast, which eventually grew to 25 cm by 10 cm and began to rapidly bleed and ulcerate within 3 months. The patient had visible signs of anemia and significant emaciation as a result of the tumor’s wasting effect and the protracted course of the disease. The patient underwent modified radical mastectomy on the right breast. The pathology results obtained after surgery revealed a malignant phyllodes tumor. No adjuvant therapy, such as chemotherapy or radiation, was administered. The patient had no symptoms of tumor recurrence and complications from the surgery after a follow-up of 9 months.[Keywords] Breast cancer; Malignant phyllodes tumor; Diagnosis; Complications; Pathology1.IntroductionPhyllodes tumors of the breast (PTB), formerly known as ”cystosarcoma phyllodes,” are relatively rare in clinical practice, and they account for 0.3%–1% of breast tumors[1]. According to the histological features, the World Health Organization currently divides PTB into three categories, namely benign, borderline (also known as low-grade malignant PTB), and malignant (also known as high-grade malignant PTB)[2]. PTB rarely affects men, and typically affects women between 40 and 50 years of age[3]. In most cases, the clinical signs are unilateral, typically exhibited as a painless mass, and there may be a history of quick growth.The high-risk factors and pathogenesis of PTB are currently unclear. There are hypotheses suggesting that PTB originates from fibroadenomas, but there is still a significant debate[4]. High estrogen status may also be an independent pathogenic factor for PTB[5]. This tumor is a fibroepithelial tumor that contains both stromal and epithelial components. Reduction of the epithelial component is associated with greater malignancy. The characteristics of phyllodes tumors are composed of proliferative stroma accompanied by elongated fissure-like gaps, with the surface of the gaps covered by epithelium. Chromosomal changes are associated with the malignant phenotype of PTB. In borderline and malignant PTB, chromosome 1q amplification is common, and as the degree of amplification increases, malignant behavior increases[6, 7].Phyllodial breast tumors are generally rare, however, their incidence rates have increased in recent years. The clinical manifestations of phyllodial tumors lack specific characteristics but include insidious onset, slow progression, a long medical history, and the main manifestation being rapid growth of painless masses in the affected breast. These characteristics make it difficult to determine the nature of phyllodial tumors without surgery. In the present study, we report a case of a giant malignant phyllodial tumor and emphasize the importance of ”detect, diagnose, and treat early” to avoid serious complications.Case presentation 2.1 Background of the caseA 48-year-old woman with a right breast tumor was admitted to the hospital on February 2, 2023. Six years ago, the patient discovered the tumor in her right breast by chance. The tumor was left untreated and showed no signs of redness, swelling, pain, or ulceration. Three months ago, following a COVID-19 infection, the right breast’s lump rapidly grew, accompanied by bleeding and ulceration but without purulent secretion.2.2 Physical examination and laboratory testsPhysical examination of the patient revealed pale nail beds on both hands, pale eyes, and an anemic face. The skin in the right breast’s lateral quadrant was pigmented, with surface ulceration and bleeding, and the right breast was noticeably bigger than the left one. The left breast showed no signs of skin redness, swelling, nipple depression, dimples, or orange peel sign. The right breast was noticeably enlarged, and the tumor measuring roughly 25 cm by 10 cm protruded from the skin (Figures 1 and 2). The left breast did not have any discernible bulk. There were no swollen lymph nodes palpable in the bilateral supraclavicular area or left armpit, but there was a lymph node measuring roughly 2 cm by 1 cm in the right armpit. Ultrasound examination revealed a mixed echogenic mass of approximately 20 cm by 5.2 cm in the right breast. Blood flow signals were present within the bulk, and the boundary was clearly defined despite the uneven shape. In addition, ultrasound indicated hyperplastic alterations in the left breast. The left axillary region did not appear to have any noticeable anomalous lymph nodes. The right armpit revealed many lymph nodes, and the largest one was 1.6 cm by 0.6 cm in size and had a thicker cortex compared with the normal cortex. Ultrasonography of the right breast tumor indicated that the lesion was BI-RADS4 class 4b (Figure 3). Positron emission tomography–computed tomography (PET-CT) was also performed, and the right breast mass could not be ruled out as a phyllodes tumor with malignant transformation due to (1) its heterogeneous metabolism and mixed density; (2) elevated metabolism of lymph nodes situated in the right axilla and behind the pectoralis major and minor muscles, possibly suggesting the presence of metastasis; (3) slight inflammation in the upper and lower lobes of both lungs; an inflammatory small nodule in the upper lobe of the right lung; localized emphysema in the upper lobe of the right lung; and anemia. Puncture pathology of the right breast fibroepithelial tumor did not show any conclusive indications of malignancy. Because fibroepithelial tumors are heterogeneous and biopsy tissue is limited, it is important to integrate clinical information and, if necessary, perform full lesion resection. Owing to the tumor’s massive size and ulceration, the patient’s blood routine test revealed mild anemia (hemoglobin, 75 g/L) and infection (white blood cell count, 13.68×109/L). Hemoglobin level reached 99 g/L following a 400 mL leukocyte-free suspended red blood cell transfusion and using cephalosporin drugs to treat inflammation.2.3 TreatmentPreoperative diagnosis was a right breast phyllodes tumor (high likelihood of malignancy), and right axillary lymph node metastasis was highly probable. A modified radical mastectomy of the right breast was carried out (Figure 4). About 40 mL of blood was lost during the successful procedure.General morphology of surgical specimens: There was a large lobulated mass in the breast tissue (22 cm × 21 cm × 7.5 cm), with a solid and tough cut surface. The total volume of the breast and axilla measured 24 cm × 23 cm × 8 cm; the area of the spindle skin measured 24 cm × 17 cm; and the diameter of the nipple was 1.8 cm. The breast did not contain any normal glands. The tumor was located 0.1 cm from the superficial fascia. Locally, the tumor affected the skin. A single adipose tissue mass of 8 cm × 7 cm × 2 cm was discovered, and 25 lymph nodes with a diameter of 0.3–2 cm were palpable inside the mass. Microscopic examination (Figure 5) showed a 22 cm × 21 cm × 7.5 cm malignant phyllodes tumor in the right breast. Low-grade fibrosarcoma, characterized by localized ossification, intrusion into the duct to generate papilloma-like morphology, and myofibroblastic differentiation, constituted the sarcoma component. The tumor lacked a distinct capsule, most of which exhibit expansion and progressive growth, local skin invasion, and formation of skin ulcers. The tumor cells showed a wide range of morphologies, including myxoid, sparse, dense, and collagenized cells, and presented mild to severe atypia. Mitotic figures were found in 1–7/10 HPFs. No tumor metastases were found in the axillary lymph nodes, and there was no tumor infiltration of the papillary or superficial fascia (0/25). The postoperative pathological(Figure 6) diagnosis was a malignant breast phyllodes tumor. Immunohistochemistry: -3: CK5/6(−), CKpan(−), SATB2(+), ER(−); -8: Ki-67 (+20%), β-catenin (membrane +), CKpan (−), CD34 (+), CD31 (blood vessels +); -11: Ki-67 (+10% to 20%), Desmin (−), Calponin (foci+), S-100 (−), β-catenin (membrane +).2.4 Outcome and follow-upAfter surgery, the patient made a full recovery. Half a month after the operation, hemoglobin level improved (92 g/L), and no adjuvant therapy, such as chemotherapy or radiation, was administered. At a follow-up 9 months after surgery, the patient has not experienced any associated problems or indications of tumor recurrence thus far.

Basile Njei

and 6 more

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly impacts global health, with a prevalence affecting roughly 25% of adults worldwide. GLP-1 receptor agonists (GLP-1RAs) offer potential therapeutic benefits beyond glycemic control, including improvement in hepatic steatosis, inflammation, and fibrosis. Objectives: This study aims to systematically review and meta-analyze randomized clinical trials to evaluate the efficacy and safety of GLP-1RAs in MASLD patients, focusing on hepatic outcomes, cardiovascular outcomes, anthropometric measurements, and mortality. Methods: Following PRISMA guidelines, a comprehensive database search was conducted to include RCTs assessing GLP-1RAs’ effects on MASLD. Quality assessment was conducted using the Revised Cochrane Risk of Bias tool. Our meta-analysis utilized a random-effects model, calculating standardized mean differences for continuous outcomes to determine the agents’ efficacy and safety. Additionally, funnel plots were generated to assess publication bias, ensuring the integrity of our meta-analytical findings. Results: The review included 27 trials, revealing GLP-1RAs significantly improved hepatic function markers (ALT, AST, GGT, and liver fat content) and cardiovascular risk factors (fasting blood sugar, HbA1c levels, lipid profiles). Additionally, GLP-1RAs were associated with significant reductions in body weight, BMI, subcutaneous fat, and waist circumference. Conclusion: GLP-1RAs demonstrate a promising therapeutic role in managing MASLD, offering benefits that extend to improving liver function, mitigating cardiovascular risk, and promoting weight loss. Further research is needed to confirm these findings and optimize GLP-1RAs’ usage in MASLD treatment.
Land use land cover change is the main factor which contributed to biodiversity loss, and has affected negatively human wellbeing. Understanding this phenomenon is important in Riverine area of Pendjari Reserve which has been affected by anthropic disturbance for century years, and is, nowadays, one of the most significantly biodiversity hotspots in the West Africa. This study aims to (i) assess the trends of land use land cover change from 1998 to 2020; (ii) predict the future of land use land cover change for 2035 and 2050. Landsat images were used to determine LULC dynamics for the years 1998, 2007, 2013 and 2020 using Random Forest classification in ArcGIS software while the predicted LULC of 2035 and 2050 were simulated using Terset 18.21. The results indicated significant changes in LULC patterns. The wooded savannah decreased by 4.7 %, 8 % and 11.5 % respectively during 1998-2007, 2007-2013 and 2013-2020. While shrub savannah increased by 10.5% and 3.88 % respectively 1998-2007 and 2007-2013 before declined by 1.17%. However, the cropland from 1998-2007 decreased by 6.66 %, before increased by 4.33% and 11.1% respectively from 2007-2013 and 2013-2020. Fallow land increased by 0.77 %, 0.83 % respectively 1998-2007 and 2013-2020, before decreasing by 0.7 % in 2007-2013. Settlement area increased from 1998-2020. The prediction results confirmed small decreased of wooded savannah and increased shrub savannah, cropland and fallow. Moreover, results of 2035 predicted settlement decreased in future and suggest African partnership will continuous for better land management of this study area. For year 2050, the wooded savannah will increase by 17506.7 Ha with 583.557 Ha/year -1 rate of change.

Mayura Shinde

and 15 more

Background: Pregnant individuals are at high risk for developing severe illness related to COVID-19. We adapted the “COVID-19 infectiOn aNd medicineS In pregnancy” (CONSIGN) CONSIGN study protocol as part of an international collaboration to understand the natural history of COVID-19 disease among pregnant individuals in the U.S. Methods: We identified individuals aged 12 to 55 years with documented live-birth deliveries in the Sentinel Distributed Database who had at least one qualifying diagnosis for COVID-19 or positive-confirmed nucleic acid amplification test for SARS-CoV-2. We conducted separate 1:1 propensity score matched analyses comparing pregnant individuals with COVID-19 to: 1) pregnant individuals without COVID-19 during six months prior to or during pregnancy; and 2) non-pregnant individuals with COVID-19. Results: From January 2020 to December 2022 , we identified 52,355 pregnant individuals with COVID-19 matched to 52,355 pregnant individuals without COVID-19. Outpatient medication use in the 30 days surrounding COVID-19 date (or matched date) was generally low but similar between pregnant individuals with and without COVID-19. We identified 40,518 pregnant individuals with COVID-19 matched to 40,518 non-pregnant individuals with COVID-19. Medication use in 30 days prior to COVID-19 was higher among non-pregnant than pregnant individuals with COVID-19. More pregnant individuals than matched non-pregnant individuals were classified as non-severe (87.2% vs. 79.9%); however, more non-pregnant individuals could not have their COVID-19 severity determined (19.0% vs. 10.0%). Conclusions: Medication use is generally low in pregnancies with COVID-19, compared to pregnancies without COVID-19 and non-pregnant individuals with COVID-19. Interpretation of medication utilization patterns is challenging due to changing treatment and prevention recommendations during the pandemic.

Felipe Bernardi

and 6 more

This study presents a comprehensive analysis of baseflow separation techniques within a small rural catchment, focusing on the calibration and application of three Recursive Digital Filters (RDFs): the Eckhardt, Lyne and Hollick (LH), and Chapman and Maxwell (CM) filters. The research aimed to refine baseflow estimation methods by calibrating the BFImax and Beta parameters of the Eckhardt’s and LH filters, respectively, using dissolved silica concentration data to derive reference baseflow. A novel event-based calibration approach was introduced, categorizing rainfall-runoff events by their magnitudes to optimize filter parameters accordingly. The findings reveal that the calibrated Eckhardt’s filter, incorporating event-specific parameter values, provides the most accurate baseflow estimations, closely aligning with observed data across various performance metrics. The event-based calibration demonstrated significant improvements in baseflow prediction accuracy, particularly for the Eckhardt’s and LH filters, compared to the general calibration approach. The study confirms the dynamic nature of the BFImax and Beta parameters, which vary with event magnitude, underscoring the importance of tailored calibration strategies for precise baseflow separation. The CM filter, while offering plausible baseflow hydrograph shapes and peak timings, was limited by its lack of adjustable parameters, leading to consistent underestimation of baseflow volumes. In contrast, the adjustable parameters of the Eckhardt’s and LH models enabled a more accurate representation of baseflow dynamics, particularly when calibrated for specific event magnitudes. This research confirms the superior efficacy of the Eckhardt’s filter in baseflow separation for small rural catchments, advocating for its use with event-based calibration when tracer data is available. Overall, the findings contribute valuable insights into baseflow modeling, offering improved methodologies for hydrologists and environmental scientists to enhance water resource management and conservation strategies.

Webster-Kerr Karen

and 14 more

Background: PCR testing of respiratory tract specimens detects SARS-CoV-2 viral shedding. Previous studies show that viral RNA was detected from 1-83 days after COVID-19 symptom onset. This study aimed to estimate time to viral clearance (TVC) for COVID-19 cases from March-June 2020 in Jamaica. Methods: Cross-sectional analysis was conducted on national surveillance data. Viral clearance was defined as time from first positive nasopharyngeal swab to the first of two consecutive negative tests. Confirmed cases and clinical severity were based on WHO definitions. Frequency distributions, median and interquartile ranges (IQR) were computed. Kruskal Wallis, Mann-Whitney U and log rank tests evaluated differences by age, sex, and clinical severity. Kaplan Meier curves described TVC by characteristics. A p-value <0.05 was considered statistically significant. Results: The analysis included 431 cases. Median TVC (days) was 28.0 (IQR: 18.0). Viral clearance differed by age (p<0.05), sex (p<0.0001) and clinical severity (p<0.05). For clinical severity, mildly ill cases had longest TVC (median: 29.0 days, 95%CI: 27-31). Females had a longer TVC (median: 30.0, 95%CI: 28-31) than males (median: 23.0, 95%CI: 20-26). TVC was greater in cases <60 years (median: 28.0 days, 95%CI: 26-30) than those ≥60 years (median: 19.0 days, 95%CI: 12-27). Forty-five percent of cases were from a workplace cluster. TVC for workplace cluster versus non-workplace cluster cases was 33.0, (95%CI: 31-34) versus 20.0, (95%CI: 18-22) days. Conclusion: Median TVC was 28 days and was influenced by age, sex, clinical severity and time of testing. Future studies may be useful to clarify these differences.

Browse more recent preprints

Powerful features of Authorea

Under Review
Communities
Collections
Learn More
Journals connected to Under Review
Ecology and Evolution
Allergy
Clinical Case Reports
Land Degradation & Development
Mathematical Methods in the Applied Sciences
Biotechnology Journal
Plant, Cell & Environment
International Journal of Quantum Chemistry
PROTEINS: Structure, Function, and Bioinformatics
All IET journals
All AGU journals
All Wiley journals
READ ABOUT UNDER REVIEW
Featured Collection
READ ABOUT COLLECTIONS
Featured communities
Explore More Communities

Other benefits of Authorea

Multidisciplinary

A repository for any field of research, from Anthropology to Zoology

Comments

Discuss your preprints with your collaborators and the scientific community

Interactive Figures

Not just PDFs. You can publish d3.js and Plot.ly graphs, data, code, Jupyter notebooks

Documents recently accepted in scholarly journals

Karma Norbu

and 3 more

Introduction: Scrub typhus is a neglected life threatening acute febrile illness caused by bacteria Orientia tsutsugamushi and it is a vector-borne zoonotic disease. In 2009, scrub typhus outbreak at Gedu has awakened Bhutan on the awareness and testing of the disease.Information and data of the study highlights the need for in depth surveillance, awareness among prescribers and initiate preventive measures in the country. Methods: We used retrospective descriptive study through review of laboratory registers across three health centres in Zhemgang district, south central Bhutan. The laboratories registers have been transcribed into CSV file using Microsoft excel. Variables of interest were collected from the registers and then analysed using open statistical software R, (R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.) And use of mStats package, (MyoMinnOo (2020). mStats: Epidemiological DataAnalysis. R package version 3.4.0.) Results: Of the total 922 tests prescribed for suspected scrub typhus in the three health centers in Zhemgang, only 8.2 % (n=76) were tested positive. Of these, Panbang Hospital had highest reported positive for scrub typhus with 56.6 %( n=43) followed by Yebilaptsa Hospital 35.5 %( n=27) and Zhemgang Hospital with 7.9 %( n=6). The female gender is comparably more affected as opposed to male with 57.9% (n=44) of the positive cases being female. The prevalence of scrub typhus seems to be affected by the seasonal variation as the months of Spring, Summer and Autumn together accounts for 98.7%(n=75) of total positive cases. The year 2019 noted significant scrub typhus cases accounting to 89.5 %(n=68) of the total positive cases over the two years. Conclusions:The overall tests tested positive of the scrub typhus infection within two years was 8.2%.

Browse more published preprints

Featured templates
Featured and interactive
Journals with direct submission
Explore All Templates